CNS Network

Garden Grove, California 92845

1 studies enrolling now · 12 studies all time

What they study most

ADHD, Adjunctive Treatment of Major Depressive Disorder, Major Depressive Episode, SARS-CoV-2 Infection, Schizophrenia, Suicidality, Treatment Resistant Depression

Studies at this site

• A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia — Recruiting now
• A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment — Completed
• Guided ADHD Therapy for Managing the Extent and Severity of Symptoms — Completed
• A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD — Completed
• Medibio DDA Confirmatory Performance Study — Completed
• Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults — Running, not enrolling
• Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment — Stopped early
• Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment — Completed
• A Twelve Week, Open Label Extension Study in Patients With Schizophrenia — Completed
• A Study to Evaluate The Effects of RO5545965 in Participants With Negative Symptoms of Schizophrenia Treated With Antipsychotics — Completed
• Safety and Tolerability Study of Drug to Treat Schizophrenia — Completed
• A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia — Completed